Do you continue TNF inhibitors in patients with a new diagnosis of CLL?
Patient with long standing history of HLAB27 associated uveitis on adalimumab and new diagnosis of CLL.
1 Answer
Mednet MemberInvited Expert
Rheumatology · Johns Hopkins School of Medicine
Answered on
If the patient does not require any treatments for CLL that are potentially immunosuppressive, I would continue TNF-inhibitor therapy in this setting. It is always helpful to discuss the case with the patient's hematologist/oncologist to make sure everyone is comfortable with the plan.
Join for free or sign in to see the full answer